27582-14-5 Usage
Uses
Used in Pharmaceutical Processes:
4-Pyridinamine, 2-methyl-3-nitro-, is used as an intermediate in the synthesis of various pharmaceutical compounds. Its unique structure allows it to be a key component in the development of new drugs, contributing to the advancement of medicinal chemistry.
Used in Chemical Synthesis:
4-Pyridinamine, 2-methyl-3-nitrois employed as a building block in the synthesis of other organic substances. Its reactivity and functional groups make it a valuable asset in the creation of complex molecules, which can be utilized in various industries, including the production of dyes, agrochemicals, and other specialty chemicals.
Used in Research and Development:
4-Pyridinamine, 2-methyl-3-nitro-, is utilized in research settings to study its properties, reactivity, and potential applications. It serves as a model compound for understanding the behavior of similar compounds within the pyridine group, aiding in the development of new synthetic methods and applications.
Check Digit Verification of cas no
The CAS Registry Mumber 27582-14-5 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,7,5,8 and 2 respectively; the second part has 2 digits, 1 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 27582-14:
(7*2)+(6*7)+(5*5)+(4*8)+(3*2)+(2*1)+(1*4)=125
125 % 10 = 5
So 27582-14-5 is a valid CAS Registry Number.
27582-14-5Relevant academic research and scientific papers
The synthesis of 6-deazaformycin A
Tite, Tony,Lougiakis, Nikolaos,Marakos, Panagiotis,Pouli, Nicole
scheme or table, p. 2927 - 2930 (2010/02/28)
The synthesis of the new C-nucleoside 6-deazaformycin A was achieved through the condensation of a suitably substituted lithiated 2-picoline with 2,3,5-tri-O-benzyl-d-ribonolactone, borohydride reduction of the resulting hemiacetals, followed by intramolecular Mitsunobu cyclization of the carbinols, manipulation of the protecting groups, and subsequent ring closure to result in the formation of 7-amino-3-(β-d-ribofuranosyl)pyrazolo[4,3-b]pyridine. Georg Thieme Verlag Stuttgart.
